GSK Investigational Site

Evanston, Illinois 60201

0 studies enrolling now · 8 studies all time

What they study most

Anaemia, Arthritis, Rheumatoid, Asthma, Hypertrophy, Left Ventricular, Lung Cancer, Non-Small Cell, Pain, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma — Completed
• A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis — Completed
• A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis — Completed
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed
• The CLEVER Study - Coreg And Left Ventricular Mass Regression — Completed